Trial Summary
What is the purpose of this trial?
Nearly 90% of people with Parkinson's disease have speech and voice disorders that negatively impact their ability to communicate effectively in daily life. This study will test the hypothesis that a combined speech and exercise intervention will improve speech intelligibility in people with Parkinson's disease and speech impairment. This approach would offer an affordable way to continue to both instruct and encourage training by Veterans virtually indefinitely through the remote access technology. These findings may help VA clinicians provide optimal care for the many Veterans with Parkinson's disease and speech impairment.
Do I have to stop taking my current medications for the trial?
The protocol does not specify if you need to stop taking your current medications. However, since participants must respond to dopaminergic medication, it seems likely you will continue taking it.
What data supports the idea that Speech and Exercise Therapy for Parkinson's Disease is an effective treatment?
The available research shows that while exercise programs and rehabilitation are not always essential when motor disorders are controlled by medication, they become necessary when motor decline occurs. Exercise therapy, especially goal-based task-specific training, has been found effective in improving motor symptoms. Studies indicate that physical exercise, including speech therapy, can improve mobility, balance, and speech problems in Parkinson's patients. However, the effects on reducing daily life disability are more significant than on specific symptoms like tremor. New studies highlight improvements in movement and balance through strength training and rhythmic exercises, suggesting that these therapies can help patients manage their condition better.12345
What safety data exists for speech and exercise therapy in Parkinson's disease?
The available research indicates that exercise and motor training are beneficial for people with Parkinson's disease, but there is limited reporting on adverse events in clinical trials. A systematic review found that 72% of trials did not report adverse events, which poses challenges for assessing safety. However, the Lee Silverman Voice Treatment, a specific speech therapy, has been shown to relieve speech problems in Parkinson's patients. Overall, while the benefits of exercise and speech therapy are recognized, more consistent reporting on safety and adverse events is needed.35678
Is the combined speech and exercise treatment a promising treatment for Parkinson's disease?
Research Team
David William Sparrow, DSc
Principal Investigator
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Eligibility Criteria
This trial is for people with Parkinson's disease who have speech and voice disorders known as hypokinetic dysarthria. Participants must have a diagnosis of idiopathic PD, show at least two key symptoms (resting tremor, rigidity, bradykinesia), and respond to medication for PD. Those with recent heart issues or requiring therapy for irregular heartbeat cannot join.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Combined speech and exercise intervention (Behavioral Intervention)
- Health education (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor